A Phase I Clinical Trial of the hu14.18-IL2 (EMD 273063) as a Treatment for Children with Refractory or Recurrent Neuroblastoma and Melanoma: a Study of the Children's Oncology Group
Osenga, K. L.Volume:
12
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-05-2000
Date:
March, 2006
File:
PDF, 320 KB
english, 2006